BACKGROUND: Hypoglycaemic events, particularly nocturnal, affect health-related quality of life (HRQoL) via acute symptoms, altered behaviour and fear of future events. We examined the respective disutility associated with a single event of daytime, nocturnal, severe and non-severe hypoglycaemia. METHODS: Representative samples were taken from Canada, Germany, Sweden, the United States and the United Kingdom. Individuals completed an internet-based questionnaire designed to quantify the HRQoL associated with different diabetes- and/or hypoglycaemia-related health states. HRQoL was measured on a utility scale: 1 (perfect health) to 0 (death) using the time trade-off method. Three populations were studied: 8286 respondents from the general po...
Aim To conduct a systematic review of published studies reporting on the longitudinal impacts of hyp...
AbstractObjectiveNonsevere hypoglycemic events are common and may occur in one-third of persons with...
Hypoglycemia is a limiting factor to achieving optimal glycemic control in patients with type-2 diab...
BACKGROUND: Hypoglycaemic events, particularly nocturnal, affect health-related quality of life (HRQ...
AbstractObjectiveThe aim of this study was to investigate the impact of hypoglycemia according to se...
Aim: To characterise the impact of increasing severity and frequency of hypoglycaemia on utility, qu...
258-258Objectives: To study the effect of nocturnal and daytime non-severe hypoglycaemic events on t...
Purpose Non-severe nocturnal hypoglycemic events (NSNHEs) are hypoglycemic events that occur during ...
AIMS: Data on the impact of hypoglycaemia on patients' daily lives and diabetes self-management, par...
Stewart B Harris,1 Kamlesh Khunti,2 Mona Landin-Olsson,3 Claus B Galbo-Jørgensen,4 Mette B&os...
Aims: Research on hypoglycaemia and quality of life (QoL) has focused mostly on severe hypoglycaemia...
Abstract Background Consideration of health-related quality of life (HRQOL) in diabetes has been ass...
AIMS: Research on hypoglycaemia and quality of life (QoL) has focused mostly on severe hypoglycaemia...
AbstractObjectivesHypoglycemia is a common complication of treatment with certain diabetes drugs. No...
AIMS: The Hypoglycaemia Assessment Tool (HAT) study investigated the health economic impact of hypog...
Aim To conduct a systematic review of published studies reporting on the longitudinal impacts of hyp...
AbstractObjectiveNonsevere hypoglycemic events are common and may occur in one-third of persons with...
Hypoglycemia is a limiting factor to achieving optimal glycemic control in patients with type-2 diab...
BACKGROUND: Hypoglycaemic events, particularly nocturnal, affect health-related quality of life (HRQ...
AbstractObjectiveThe aim of this study was to investigate the impact of hypoglycemia according to se...
Aim: To characterise the impact of increasing severity and frequency of hypoglycaemia on utility, qu...
258-258Objectives: To study the effect of nocturnal and daytime non-severe hypoglycaemic events on t...
Purpose Non-severe nocturnal hypoglycemic events (NSNHEs) are hypoglycemic events that occur during ...
AIMS: Data on the impact of hypoglycaemia on patients' daily lives and diabetes self-management, par...
Stewart B Harris,1 Kamlesh Khunti,2 Mona Landin-Olsson,3 Claus B Galbo-Jørgensen,4 Mette B&os...
Aims: Research on hypoglycaemia and quality of life (QoL) has focused mostly on severe hypoglycaemia...
Abstract Background Consideration of health-related quality of life (HRQOL) in diabetes has been ass...
AIMS: Research on hypoglycaemia and quality of life (QoL) has focused mostly on severe hypoglycaemia...
AbstractObjectivesHypoglycemia is a common complication of treatment with certain diabetes drugs. No...
AIMS: The Hypoglycaemia Assessment Tool (HAT) study investigated the health economic impact of hypog...
Aim To conduct a systematic review of published studies reporting on the longitudinal impacts of hyp...
AbstractObjectiveNonsevere hypoglycemic events are common and may occur in one-third of persons with...
Hypoglycemia is a limiting factor to achieving optimal glycemic control in patients with type-2 diab...